Cargando…

Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest

Background  In children, the infection with SARS-CoV-2, the cause of COVID-19, tends to be clinically inapparent more often or less severe than in adults. The spread of this infection from children poses a danger to vulnerable adults. Therefore, child care institutions and schools currently are wide...

Descripción completa

Detalles Bibliográficos
Autores principales: Reisinger, Emil C., von Possel, Ronald, Warnke, Philipp, Geerdes-Fenge, Hilte F., Hemmer, Christoph J., Pfefferle, Susanne, Löbermann, Micha, Littmann, Martina, Emmerich, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446142/
https://www.ncbi.nlm.nih.gov/pubmed/32572869
http://dx.doi.org/10.1055/a-1197-4293
_version_ 1783574110009294848
author Reisinger, Emil C.
von Possel, Ronald
Warnke, Philipp
Geerdes-Fenge, Hilte F.
Hemmer, Christoph J.
Pfefferle, Susanne
Löbermann, Micha
Littmann, Martina
Emmerich, Petra
author_facet Reisinger, Emil C.
von Possel, Ronald
Warnke, Philipp
Geerdes-Fenge, Hilte F.
Hemmer, Christoph J.
Pfefferle, Susanne
Löbermann, Micha
Littmann, Martina
Emmerich, Petra
author_sort Reisinger, Emil C.
collection PubMed
description Background  In children, the infection with SARS-CoV-2, the cause of COVID-19, tends to be clinically inapparent more often or less severe than in adults. The spread of this infection from children poses a danger to vulnerable adults. Therefore, child care institutions and schools currently are widely closed. Methods  Since the status of infection tends to be congruent in mothers and their children, we tested 401 mothers of children between 1 and 10 years in the city of Rostock (State of Mecklenburg-Westpomerania, northeast of Germany), for the presence of RNA of SARS-CoV-2 in throat swabs, and of antibodies against SARS-CoV-2 in serum. Results  In none of the mothers tested, RNA of this virus was detected in the throat swab. In the ELISA test, IgG antibodies were positive in one serum sample, IgA antibodies were positive in 11, and borderline in 3 serum samples. All 401 sera were negative in the indirect immunofluorescence test (IIFT) with FITC-labeled IgG, IgA, und IgM antibodies. Conclusion  At the time of this study, neither SARS-CoV-2 RNA, nor specific antibodies against SARS-CoV-2 were detectable in the mothers tested in Rostock.
format Online
Article
Text
id pubmed-7446142
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-74461422020-09-09 Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest Reisinger, Emil C. von Possel, Ronald Warnke, Philipp Geerdes-Fenge, Hilte F. Hemmer, Christoph J. Pfefferle, Susanne Löbermann, Micha Littmann, Martina Emmerich, Petra Dtsch Med Wochenschr Background  In children, the infection with SARS-CoV-2, the cause of COVID-19, tends to be clinically inapparent more often or less severe than in adults. The spread of this infection from children poses a danger to vulnerable adults. Therefore, child care institutions and schools currently are widely closed. Methods  Since the status of infection tends to be congruent in mothers and their children, we tested 401 mothers of children between 1 and 10 years in the city of Rostock (State of Mecklenburg-Westpomerania, northeast of Germany), for the presence of RNA of SARS-CoV-2 in throat swabs, and of antibodies against SARS-CoV-2 in serum. Results  In none of the mothers tested, RNA of this virus was detected in the throat swab. In the ELISA test, IgG antibodies were positive in one serum sample, IgA antibodies were positive in 11, and borderline in 3 serum samples. All 401 sera were negative in the indirect immunofluorescence test (IIFT) with FITC-labeled IgG, IgA, und IgM antibodies. Conclusion  At the time of this study, neither SARS-CoV-2 RNA, nor specific antibodies against SARS-CoV-2 were detectable in the mothers tested in Rostock. © Georg Thieme Verlag KG 2020-08 2020-06-22 /pmc/articles/PMC7446142/ /pubmed/32572869 http://dx.doi.org/10.1055/a-1197-4293 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Reisinger, Emil C.
von Possel, Ronald
Warnke, Philipp
Geerdes-Fenge, Hilte F.
Hemmer, Christoph J.
Pfefferle, Susanne
Löbermann, Micha
Littmann, Martina
Emmerich, Petra
Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
title Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
title_full Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
title_fullStr Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
title_full_unstemmed Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
title_short Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
title_sort mütter-screening in einem covid-19-niedrig-pandemiegebiet: bestimmung sars-cov-2-spezifischer antikörper bei 401 rostocker müttern mittels elisa und immunfluoreszenz-bestätigungstest
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446142/
https://www.ncbi.nlm.nih.gov/pubmed/32572869
http://dx.doi.org/10.1055/a-1197-4293
work_keys_str_mv AT reisingeremilc mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT vonposselronald mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT warnkephilipp mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT geerdesfengehiltef mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT hemmerchristophj mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT pfefferlesusanne mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT lobermannmicha mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT littmannmartina mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest
AT emmerichpetra mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest